BBLGWBone Biologics Corp Warrants
8.240USD0.00%Mkt Cap: —P/E: —4d ago
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromoti…
Industry Peers
Chemicals$49.67BUSDP/E 21.7
$23.37BUSD
$8.86BUSD
$5.14BUSD
$4.39BUSDP/E 37.1
$4.67BUSDP/E 67.9
$4.65BUSDP/E 68.3
$2.90BUSDP/E 850.7
$2.73BUSDP/E 17.9
$2.10BUSD
$1.92BUSDP/E 14.1
$1.80BUSDP/E 16.7
$1.75BUSD
$1.54BUSDP/E 14.2
$1.47BUSDP/E 16.0
$1.27BUSDP/E 12.2
$1.14BUSDP/E 9.7
$1.25BUSD
$887.93MUSD
$800.61MUSDP/E 22.2
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-3.11M $
Revenue/Share—
Last Price8.240 USD
Fiscal Year End—
MR Quarter—
Employees2
CountryUS
SectorBasic Materials
IndustryChemicals
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B2.75
EPS (TTM)-0.14
EPS (Forward)—
52W Range
3.50015% of range35.95
52W High35.95 USD
52W Low3.500 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-57.81%
ROA-53.64%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.69M $
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-4.53M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio16.09
Quick Ratio14.67
Book Value/Sh2.995 USD
Cash/Share2.523 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float1.79M
Insiders—
Institutions—
Technical
SMA 5011.56 (-28.7%)
SMA 20017.85 (-53.8%)
Beta0.53
S&P 52W Chg18.16%
Avg Vol (30d)507
Avg Vol (10d)210
Technical Indicators
RSI (14)41.1
MACD-1.7836
MACD Signal-1.8146
MACD Hist.+0.0311
BB Upper16.04 USD
BB Middle9.955 USD
BB Lower3.869 USD
BB Width122.28%
ATR (14)1.128 USD
Vol Ratio (20d)0.00x